Requirements of the RNA Polymerase II C-Terminal Domain for Reconstituting Pre-mRNA 3′ Cleavage

Por Ryan, Kevin, Murthy, Kanneganti G. K., Kaneko, Syuzo, Manley, James L.
Publicado em 2002

High mobility group protein-1 (HMG-1) is a unique activator of p53

Por Jayaraman, Lata, Moorthy, Narayani Chandra, Murthy, Kanneganti G.K., Manley, James L., Bustin, Michael, Prives, Carol
Publicado em 1998

Comparison of Inflammation, Organ Damage, and Oxidant Stress Induced by Salmonella enterica Serovar Muenchen Flagellin and Serovar Enteritidis Lipopolysaccharide

Por Liaudet, Lucas, Murthy, Kanneganti G. K., Mabley, Jon G., Pacher, Pál, Soriano, Francisco G., Salzman, Andrew L., Szabó, Csaba
Publicado em 2002

The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes

Por Mabley, Jon G, Pacher, Pal, Murthy, Kanneganti G K, Williams, William, Southan, Garry J, Salzman, Andrew L, Szabo, Csaba
Publicado em 2008

THE NOVEL INOSINE ANALOGUE INO-2002 EXERTS AN ANTI-INFLAMMATORY EFFECT IN A MURINE MODEL OF ACUTE LUNG INJURY

Por Mabley, Jon G., Pacher, Pal, Murthy, Kanneganti G.K., Williams, William, Southan, Garry J., Salzman, Andrew L., Szabo, Csaba
Publicado em 2009

Lung-protective effects of the metalloporphyrinic peroxynitrite decomposition catalyst WW-85 in interleukin-2 induced toxicity

Por Maybauer, Dirk M., Maybauer, Marc O., Szabó, Csaba, Westphal, Martin, Traber, Lillian D., Enkhbataar, Perenlei, Murthy, Kanneganti G. K., Nakano, Yoshimitsu, Salzman, Andrew, Herndon, David N., Traber, Daniel L.
Publicado em 2008